MELISSA MOBLEY: Open Payments
NPI 1033883947 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 32 payments from 11 companies in 2025. Trend: 2023 $172 · 2024 $543 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $141 |
| PFIZER INC. | 5 | $89 |
| ABBVIE INC. | 3 | $69 |
| Amgen Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| QOL Medical, LLC | 2 | $49 |
| Exact Sciences Corporation | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: Wegovy, PREVNAR 20, QULIPTA, Sucraid, EVENITY, TRELEGY ELLIPTA, Cologuard Collection Kit, Ozempic.
Industry payments across MI — which companies pay providers there.
